Interestingly, gene pathways that were upregulated by MENIN/DOT1L inhibitors include a pathway for negative cell proliferation (Supplementary Figure S5H), which may contribute to their potent inhibition of MLLr leukemia. Here, DOT1L is linked to leukemia.